Anupam Rasayan India (ANURAS) — Offer Document | StockFin

StockFin.ai

Try Free

Anupam Rasayan India Limited announced that SBI Capital Markets has filed a Draft Letter of Offer with SEBI for a mandatory open offer to acquire up to 2,77,26,848 shares (26% of expanded voting capital) in Bliss GVS Pharma Limited at ₹299 per share. The offer, triggered by a share purchase agreement to acquire 43.30% of Bliss GVS Pharma, will commence on 16 July 2026 and close on 29 July 2026. The maximum consideration is [amount not verified]. The filing includes detailed disclosures on offer terms, financial arrangements, risk factors, and procedural guidelines for shareholders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This

About Anupam Rasayan India Limited (ANURAS)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹15,665.53 Cr P/E: 68.4 ROE: 6.0% ROCE: 9.7%

View full ANURAS stock details →

📡 Get AI alerts when ANURAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANURAS — Free

💡 Ask AI about this filing

"How does this offer document affect Anupam Rasayan India Limited's outlook?" "What did Anupam Rasayan India Limited announce on 9 June 2026?" "Is this positive or negative for ANURAS?"

Ask AI Free →

📊 More ANURAS filings

See all ANURAS filings →

🔥 Also filed on 9 June 2026

RBLBANK RBL Bank Limited Insider Trading QUESS Quess Corp Limited Corporate Action RGL Renaissance Global Limited Announcement RHFL Reliance Home Finance Limited Announcement RITCO Ritco Logistics Limited Announcement RKFORGE Ramkrishna Forgings Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ANURAS files new disclosures

Track ANURAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANURAS — Free

Free account · 2 AI queries/day